Of the funding, $1 billion goes to 4 BARDA research partners to support phase 2b clinical trials of vaccine candidates.
HHS awards $1.4 billion for Project NextGen COVID countermeasures
More from COVID-19More posts in COVID-19 »
- Data suggest SARS-CoV-2 could jump from raccoon dogs to people, but species barrier may interfere
- Quick takes: Moderna’s RSV vaccine, flu-COVID combo vaccines, new polio cases
- Study: US children at times received ineffective COVID-19 treatments
- NIH announces long-COVID trials to examine treatments for sleep, exercise disruptions